Tamoxifen (ICI 46,474) and the human carcinoma 8S oestrogen receptor.
about
Estrogen receptor beta-selective agonists stimulate calcium oscillations in human and mouse embryonic stem cell-derived neuronsTamoxifen: catalyst for the change to targeted therapyTamoxifen (ICI46,474) as a targeted therapy to treat and prevent breast cancerFourteenth Gaddum Memorial Lecture. A current view of tamoxifen for the treatment and prevention of breast cancerA note from history: Landmarks in history of cancer, part 7.Tamoxifen as the first targeted long-term adjuvant therapy for breast cancerTamoxifen for the prevention of breast cancer in the high-risk woman.PharmGKB summary: tamoxifen pathway, pharmacokineticsOestradiol stimulates tyrosine phosphorylation and hormone binding activity of its own receptor in a cell-free system.Tamoxifen: a most unlikely pioneering medicine.The evolution of nonsteroidal antiestrogens to become selective estrogen receptor modulatorsTamoxifen inhibition of kv7.2/kv7.3 channelsProven value of translational research with appropriate animal models to advance breast cancer treatment and save lives: the tamoxifen tale.Expression of an estrogen-regulated variant transcript of the peroxisomal branched chain fatty acid oxidase ACOX2 in breast carcinomasThe new biology of estrogen-induced apoptosis applied to treat and prevent breast cancer.Influence of 17- alpha-estradiol on catecholamine secretion from the perfused rat adrenal glandAltered regulation of PDK4 expression promotes antiestrogen resistance in human breast cancer cellsThe Dual Estrogen Receptor α Inhibitory Effects of the Tissue-Selective Estrogen Complex for Endometrial and Breast Safety.The St. Gallen Prize Lecture 2011: evolution of long-term adjuvant anti-hormone therapy: consequences and opportunities.Activated estrogens and antiestrogens: a 30-year journey with David Kupfer.Models and Mechanisms of Acquired Antihormone Resistance in Breast Cancer: Significant Clinical Progress Despite Limitations.Breast cancer bone metastasis and current small therapeutics.Development and evolution of therapies targeted to the estrogen receptor for the treatment and prevention of breast cancer.SERMs for the treatment and prevention of breast cancer.SEARCHBreast: a new resource to locate and share surplus archival material from breast cancer animal models to help address the 3Rs.Exploiting the apoptotic actions of oestrogen to reverse antihormonal drug resistance in oestrogen receptor positive breast cancer patients.New insights into the metabolism of tamoxifen and its role in the treatment and prevention of breast cancer.Selective estrogen receptor modulators and phytoestrogens.Long-term adjuvant tamoxifen therapy for breast cancer.Utilization of human nuclear receptors as an early counter screen for off-target activity: a case study with a compendium of 615 known drugs.Hormone receptor assays: clinical usefulness in the management of carcinoma of the breast.The development of tamoxifen for breast cancer therapy: a tribute to the late Arthur L. Walpole.Chemosuppression of breast cancer with tamoxifen: laboratory evidence and future clinical investigations.Tamoxifen treatment of advanced breast carcinoma.Metabolites of tamoxifen in animals and man: identification, pharmacology, and significance.Attenuation of estrogen receptor alpha (ERalpha) signaling by selenium in breast cancer cells via downregulation of ERalpha gene expression.Third annual William L. McGuire Memorial Lecture. "Studies on the estrogen receptor in breast cancer"--20 years as a target for the treatment and prevention of cancer.Endometrial cancer. Management of high risk and recurrence including the tamoxifen controversy.Chemoprevention with antiestrogens: the beginning of the end for breast cancer. Daniel G. Miller Lecture.A unifying biology of sex steroid-induced apoptosis in prostate and breast cancers.
P2860
Q21562188-B2A04308-0F9A-4261-AA34-974CF6A7A4B5Q24652988-4A71FB1C-B69E-4D9B-ABC9-A130A0DA2F13Q24670339-173B037B-93B5-4C70-B60D-20E3466B4E85Q24685693-CA34CAA1-821E-4A6B-84D0-1FCF1B364AB2Q30931923-26FB9AA2-45B9-47FF-BE95-D2DD6C7800E3Q33642104-8C29A158-9C4D-4433-ACEC-56CD89B455DBQ33837654-E0DD7B1E-FAEB-4FAE-824B-AD6D85C87837Q33855494-83BBACA8-8419-48D2-8974-030A545A61CEQ33929666-72F9C57F-D85A-4E0C-86C7-DD0240ACD5C2Q34180688-FFFD0F3B-D44E-4508-A317-A9D01573BDDCQ34315816-1589D7AB-F2A1-4602-B88B-2AC7B8787572Q35006192-D1C02173-CC3D-4849-9692-91AF730242A7Q35023715-B047F976-834E-4947-87EE-231BE16BEF22Q35693944-6893111D-4037-42E6-9EEA-6F7EB161AE87Q35827822-67DE0972-6417-4B99-8473-9423AD650689Q35938669-8FB14CEC-ED2C-40A3-A99A-0488AB5389A0Q36269713-8F99703F-98ED-4B47-9948-F574CFF167CFQ36432425-0F4197C7-3FD9-4BC4-B550-19C8611B5571Q36464743-C18122BC-F9FB-4198-AF59-39E175CE1023Q36473482-825838DD-6DB1-48F6-8F54-B1B4F0456082Q36517144-718B848B-F78D-4886-A832-601D3496177BQ36679543-9AF2C942-8BE9-4F48-986F-FF86FB6FA4B7Q36684234-0BFCB7FF-596F-49EA-8EBE-D85EB9EBA387Q36794420-760AA619-2D2F-4753-A93F-3DDE6EA43D7DQ36814409-C9137DB4-EA60-47C4-AC48-FCE37B448798Q36919229-A7169F77-9E13-40B9-A3C1-76371686348DQ36927087-CFF4916B-148F-4838-9E93-833C5DC661E8Q36984515-D1A9D564-3ED9-4B94-B86C-ACDEDD4B8EFAQ37942117-E56C26A0-2168-4133-8EDA-60716DC3D624Q38902106-4D5EB2C7-925C-4BFF-8E33-6A39F9C085E2Q39318408-4B9F2942-D3A3-4385-9667-A8A9DEF32208Q39524591-7C59681F-F131-400A-B189-BC8484ADB078Q39554511-DF7679A7-26DD-49D2-932E-96CA7CAB835FQ39583787-CA85DA0E-C751-4C48-9538-89001A19AD4DQ40105171-E81E5425-68A9-460C-AF5D-C3999A12436BQ40374886-9D5B9BC1-681D-4DAE-82AE-BC7258C9BBC9Q40952791-FC0CCE84-8039-4C1B-A551-6D787B2454B8Q40989142-B03DED44-4F94-4A6D-8155-32B34EA0D242Q43857245-922F9099-0980-40B9-A92D-7240E33F38A7Q47825566-9B704D90-A6F5-4CF6-ABC1-3BD29D96B3A1
P2860
Tamoxifen (ICI 46,474) and the human carcinoma 8S oestrogen receptor.
description
1975 nî lūn-bûn
@nan
1975年の論文
@ja
1975年論文
@yue
1975年論文
@zh-hant
1975年論文
@zh-hk
1975年論文
@zh-mo
1975年論文
@zh-tw
1975年论文
@wuu
1975年论文
@zh
1975年论文
@zh-cn
name
Tamoxifen (ICI 46,474) and the human carcinoma 8S oestrogen receptor.
@en
Tamoxifen (ICI 46,474) and the human carcinoma 8S oestrogen receptor.
@nl
type
label
Tamoxifen (ICI 46,474) and the human carcinoma 8S oestrogen receptor.
@en
Tamoxifen (ICI 46,474) and the human carcinoma 8S oestrogen receptor.
@nl
prefLabel
Tamoxifen (ICI 46,474) and the human carcinoma 8S oestrogen receptor.
@en
Tamoxifen (ICI 46,474) and the human carcinoma 8S oestrogen receptor.
@nl
P1476
Tamoxifen (ICI 46,474) and the human carcinoma 8S oestrogen receptor.
@en
P2093
P304
P356
10.1016/0014-2964(75)90119-X
P577
1975-03-01T00:00:00Z